Cann Global Limited (ASX:CGB) Cann Global Asia Update
The Board of Cann Global Limited (ASX:CGB) wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR.
Companies in the News
Medical Equipment
Fiji Kava Ltd (ASX:FIJ) To Explore Chinese Complementary Medicine and Pharmaceutical Industry Opportunities After Signing MOU
Fiji Kava Ltd (ASX:FIJ), Australian-Fijian medicinal kava health and wellness company which produces natural 'noble kava' products, today announced the signing of a Memorandum of Understanding (MOU) with PMM Company Limited to explore future opportunities to supply Fiji Kava's noble kava extract and products to the Chinese complementary medicine, personal care and pharmaceutical industries.
Cann Global Limited (ASX:CGB) Replacement March 2020 Quarterly Activities Report
On 30 April 2020, Cann Global Ltd (ASX:CGB) lodged the Company's quarterly activities and cashflow reports for the period ended 31 March 2020. This amendment includes an updated cashflow report.
Cann Global Limited (ASX:CGB) Quarterly Activities Report
In October 2019, Austrade published a report on Australia's food innovators which Cann Global Limited (ASX:CGB), through its subsidiaries T12 and HHC, is very excited to be a part of.
US and UK Investors Reach Out to Labat Africa Ltd (JSE:LAB) as the South African Group Advances Into Major Medical Cannabis and CBD Markets
The South African group, Labat Africa Ltd (JSE:LAB) which announced last year it was entering the medical CANNABIS market, is gaining the interest of High net worth and institutional investors in London and New York.
Cann Global Limited (ASX:CGB) Refinancing Extension of Notes and Re-investment
Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has entered into agreements for the refinancing of the convertible notes currently on issue through an assignment and variation arrangement.
Cann Global Limited (ASX:CGB) Half Yearly Report and Accounts
The Directors present their report together with the financial statements, on the consolidated entity (referred to hereafter as 'the Group'), consisting of Cann Global Limited ('the Company') and the entities it controlled at the end of or during the half-year ended 31 December 2019.
◂Previous Page
Medical Equipment Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
Social Media
